Nevertheless, although the creation of hiPSCs-derived lung organoids requires a lot of effort and time, their use provides unique opportunities for more accurate modeling of CF and research of therapeutic drugs aimed at restoring CFTR channel function. The gene discussed is CFTR; the disease is cystic fibrosis.